Other OTC Pharmaceuticals (Pharmacies) - Australia

  • Australia
  • Revenue in the Other OTC Pharmaceuticals market is projected to reach US$297.30m in 2024.
  • Revenue is expected to show an annual growth rate (CAGR 2024-2029) of 1.36%, resulting in a market volume of US$318.10m by 2029.
  • In global comparison, most revenue will be generated in the United States (US$4,981.00m in 2024).
  • In relation to total population figures, per person revenues of US$11.14 are generated in 2024.

Key regions: France, Australia, India, South Korea, Germany

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Other OTC Pharmaceuticals (Pharmacies) market in Australia is experiencing steady growth due to various factors such as customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Australian market play a significant role in the development of the Other OTC Pharmaceuticals (Pharmacies) market. Consumers in Australia have a strong preference for self-medication and over-the-counter products for minor ailments and common health issues. This preference is driven by factors such as convenience, cost-effectiveness, and the desire for quick relief. Additionally, the increasing awareness and acceptance of alternative medicine and natural remedies among Australian consumers contribute to the growth of the market. Trends in the market also contribute to the development of the Other OTC Pharmaceuticals (Pharmacies) market in Australia. One notable trend is the growing demand for online pharmacies, which offer convenience and a wide range of products to consumers. The rise of e-commerce platforms and the increasing use of technology for healthcare purposes have facilitated the growth of online pharmacies in Australia. Another trend is the expansion of product offerings in pharmacies, with many pharmacies now stocking a diverse range of OTC pharmaceuticals to cater to the evolving needs and preferences of consumers. Local special circumstances in Australia further impact the development of the Other OTC Pharmaceuticals (Pharmacies) market. The country's aging population and the increasing prevalence of chronic diseases create a higher demand for OTC pharmaceuticals. As the population ages, there is a greater need for products that address age-related health issues and provide relief from common ailments. Additionally, the Australian healthcare system, which provides a mix of public and private healthcare services, influences consumer behavior and purchasing decisions in the OTC pharmaceutical market. Underlying macroeconomic factors also contribute to the growth of the Other OTC Pharmaceuticals (Pharmacies) market in Australia. The country's stable economy, high disposable income levels, and favorable healthcare policies create a conducive environment for the market to thrive. The Australian government's focus on promoting self-care and reducing the burden on the healthcare system further supports the growth of the OTC pharmaceutical market. In conclusion, the Other OTC Pharmaceuticals (Pharmacies) market in Australia is developing due to customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. The strong preference for self-medication, the rise of online pharmacies, and the expanding product offerings in pharmacies are driving the market growth. The aging population, the healthcare system, and the favorable macroeconomic conditions in Australia also contribute to the development of the market.

Methodology

Data coverage:

The data encompasses B2C enterprises. Figures are based on offline and online spending by consumers, including VAT. Not included are B2B and B2G sales, or other pharmaceutical sales through hospitals or retail stores such as supermarkets.

Modeling approach:

Market sizes are determined through a bottom-up approach, building on specific predefined factors for each market market. As a basis for evaluating markets, we use industry associations, third-party studies and reports and survey results from our primary research (e.g., the Statista Global Consumer Survey). In addition, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per country, consumer healthcare spending, GDP and internet penetration. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the relevant market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. For forecasting digital trends such as the online-pharmacy sales share we use exponential trend smoothing and the s-curve method. The main drivers are healthcare expenditure per country and consumer healthcare spending.

Additional notes:

The data is modeled using current exchange rates. The impact of the COVID-19 pandemic and the Russia-Ukraine war are considered at a country-specific level. The market is updated twice a year. GCS data is reweighted for representativeness.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Ayana Mizuno
Ayana Mizuno
Junior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)